Healthcare IT News November 20, 2020
An Intel survey of healthcare decision-makers suggests great excitement for more widespread artificial intelligence and machine learning adoption, but also some skepticism.
In a survey of hundreds of healthcare decision-makers, Intel found that the percentage of respondents whose company is currently – or will be – using artificial intelligence nearly doubled after the onset of COVID-19.
Among the predicted use cases for AI: early intervention analytics, clinical decision support and specialist collaboration. “Artificial intelligence in health and life sciences has greatly accelerated,” said Stacey Shulman, vice president of the Internet of Things Group at Intel, in a blog post accompanying the findings.
“From helping clinicians develop personalized protocols to streamlining clinical workloads or unlocking insights in genomics, infusing AI...
Today's Sponsors
Today's Sponsor